Simple Guide,privately owned CDMO based in Barcelona

BCN Peptides stands as a prominent figure in the European peptide manufacturing landscape, renowned for its commitment to quality and innovation. At the helm of this esteemed organization is Antonio Parente, the founder and president of BCN Peptides. His visionary leadership has been instrumental in shaping the company's trajectory and establishing its reputation as a reliable provider of high-quality peptides.

Founded in 1989, BCN Peptides operates as a privately held company with a steadfast focus on the industrial cGMP manufacture of Bioactive Peptides. This dedication to current Good Manufacturing Practices (cGMP) ensures that all products meet the stringent standards required for pharmaceutical and veterinary applications. The company's commitment to excellence is further underscored by its approvals from regulatory bodies such as the FDA and EDQM, a testament to its robust quality control systems.

Strategically located in Sant Quintí de Mediona, Barcelona, BCN Peptides is a privately owned CDMO based in Barcelona. This geographical advantage, coupled with its extensive experience, allows BCN Peptides to serve a global clientele seeking specialized peptide solutions. The company's expertise spans various areas, including custom synthesis and contract manufacturing, catering to diverse needs within the pharmaceutical, veterinary, and cosmetic industries.

BCN Peptides boasts a rich history of over 30 years in the field of peptides. This extensive experience has allowed them to become pioneers, particularly in the production of cosmetic peptides, where they have over 25 years of dedicated work. Their capabilities extend from milligram to multi-kilogram batch production, demonstrating their capacity to handle projects of varying scales. The company offers both bulk generic peptides and custom synthesis of novel peptide sequences, showcasing their versatility and technical prowess.

The company's organizational structure is supported by a team of dedicated professionals. While Antonio Parente serves as President, other key figures contribute to its success. Marta has been a member of the company's Board of Directors since 2017 and a director of BCN Peptides, bringing valuable governance and strategic oversight. The CEO of BCN Peptides plays a crucial role in day-to-day operations and strategic execution. Furthermore, individuals like Global Sales Director, Dr. Jordi Piró, and Dr. Catherine Owczarek represent the company's commitment to scientific engagement and global outreach. The dedication of their team is further exemplified by achievements like Iván Sánchez i Campillo, PhD, successfully defending his thesis, highlighting the company's investment in scientific development.

Historically, BCN Peptides has been associated with the Lipotec Group. However, following the acquisition of certain Lipotec businesses by The Lubrizol Corporation in 2012, BCN Peptides has continued to operate independently, maintaining its focus on peptide manufacturing. This independent operational structure allows BCN Peptides to remain agile and responsive to the evolving demands of the market.

For those seeking to collaborate or procure high-quality peptide products, BCN Peptides S.A. offers a comprehensive range of services. Their commitment to delivering excellence and innovation in peptide synthesis since 1989 makes them a trusted partner for businesses worldwide. Whether the need is for research peptides, pharmaceutical-grade APIs, or specialized cosmetic ingredients, BCN Peptides is equipped to meet the challenge. The company also actively participates in industry events, such as CPHI & PMEC India, and TIDES Europe, providing platforms for engagement and fostering new collaborations. Prospective employees interested in a career at BCN Peptides SA are encouraged to submit their CVs, as the company continuously seeks talented individuals to join its growing team.